ABSTRACT
Objective Identification of patients at high risk of knee osteoarthritis (KOA) using a noninvasive method at an earlier stage of the disease is a fundamental step in preventing disease progression. Although accumulated adipose tissue (i.e., poor quality) in the quadriceps muscle is a potent predictor of disease development, the relationship between quadriceps muscle quality and structural integrity has not been fully clarified. Using an ultrasound technique for muscle quality assessment, this study aimed to determine whether poor-quality quadriceps muscle is associated with structural abnormalities in the earlier stages of KOA.
Design This study included 49 patients (age: 44-78 years, 65.3% women) with 52 knees (Kellgren Lawrence grade 1-2). The sample size required was 46 knees. Ultrasound was used to assess the echo intensity (EI) of the vastus medialis (VM) with consideration of ultrasound wave attenuation caused by subcutaneous fat (i.e., corrected EI). Structural abnormalities were assessed using whole-organ magnetic resonance score (WORMS). A generalized linear mixed model was used to assess the relationship between corrected EI and WORMS total score. Sensitivity analysis focusing on the WORMS cartilage sub-score was conducted.
Results Increased corrected EI in the VM was significantly associated with higher joint structural abnormalities (i.e., WORMS total score) after adjustment for covariates. Sensitivity analysis revealed a similar relationship between muscle quality and WORMS cartilage sub-score.
Conclusions Patients with poor muscle quality in the VM displayed higher disease severity at an earlier stage of KOA. This study supports the use of ultrasound as a possible tool to identify patients at high risk of disease progression.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Medical Corporation Nagomi gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.